| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Fluvastatin (as fluvastatin sodium) 80 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely etodolac 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Metoclopramide hydrochloride 15 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Felodipine 5 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproate sodium 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Nifedipine 40 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Nifedipine 20 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Nisoldipine 30 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 10 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Oxycodone hydrochloride 5 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely flurbiprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Lithium carbonate 450 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
2 |
| Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Venlafaxine (as venlafaxine hydrochloride) 150 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Valproic acid 150 mg gastro-resistant oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Zinc sulfate monohydrate 125 mg effervescent oral tablet |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Tramadol hydrochloride 75 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Verapamil hydrochloride 180 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely venlafaxine (as venlafaxine hydrochloride) 75 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
4 |
| Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
3 |
| Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
2 |
| Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Vortioxetine (as vortioxetine hydrobromide) 5 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vortioxetine (as vortioxetine hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vortioxetine (as vortioxetine hydrobromide) 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Vortioxetine (as vortioxetine hydrobromide) 20 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Dolutegravir (as dolutegravir sodium) 10 mg oral tablet |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Agalsidase beta 5 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Dantrolene sodium 20 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| céfotaxime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation (clinical drug) |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Doripenem (as doripenem monohydrate) 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Alteplase 10 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| aztréonam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
2 |
| Amobarbital sodium 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Basiliximab 10 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| céfuroxime 250 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Basiliximab 20 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| chlorhydrate de diacétylmorphine 10 mg, pour injection (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
2 |
| chlorhydrate de diacétylmorphine 30 mg, pour injection (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| chlorhydrate de diacétylmorphine 100 mg, pour injection (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| chlorhydrate de diacétylmorphine 500 mg, pour injection |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Disodium pamidronate 90 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Disodium pamidronate 30 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| ceftazidime 250 mg, flacon de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| ampicilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Deferoxamine mesylate 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| clarithromycine 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
False |
milligram (qualifier value) |
Inferred relationship |
Some |
1 |
FHIR